WELLNESS CENTER USA, INC.
WELLNESS CENTER USA, INC. (WCUI): 3 pipeline candidates · ~1 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.7 months
D/E -1.22 · 0% dilution
Lead: Approved
3 candidates
N/A
N/A
A transparent, data-derived signal for WELLNESS CENTER USA, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$14K
Cash
$42K
Quarterly Burn
$297K
Runway
0.7 mo
Revenue
$108K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| losartan 25 milligram | Phase 2 |
| protec 9 | Preclinical |
| psoria-light | Approved |
Frequently asked questions
How many drug candidates are in WELLNESS CENTER USA, INC.'s pipeline?
WELLNESS CENTER USA, INC. (WCUI) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is WELLNESS CENTER USA, INC.'s lead drug candidate?
WELLNESS CENTER USA, INC.'s most advanced tracked candidate is losartan 25 milligram (Phase 2) for Radiation Induced Fibrosis.
What is WELLNESS CENTER USA, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, WELLNESS CENTER USA, INC. has approximately 0.7 months of cash runway.
What is WELLNESS CENTER USA, INC.'s market capitalization?
WELLNESS CENTER USA, INC.'s market capitalization is approximately $14K.
Who is the CEO of WELLNESS CENTER USA, INC.?
Mr. Calvin R. O'Harrow is the chief executive officer of WELLNESS CENTER USA, INC. (WCUI).
Get the full picture on WELLNESS CENTER USA, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.